Large programmes and multi-market launches

Large supplement programmes, from first batch to multi-market rollout

British VitaTech runs large supplement programmes for premium wellness brands, from first batch to multi-market rollout, with every product made in our Leicester facility. As your large-scale supplement manufacturer, we make capsules, tablets, gummies, powders, sachets and stick packs, liquids and drinks, building each formula for the strictest market on your plan and packing it into each market's labels. A named programme lead runs the programme to a written plan, with your sign-off at every gate. We group runs into campaigns, close every changeover with a documented line clearance, and every batch is tested by accredited partner laboratories and released by quality control against its specification.

What a programme needs when a retail listing or new market lands

A large-scale supplement manufacturer is tested when a programme grows faster than its plan: a retail listing lands, a second market opens or a key material runs short. We take on programmes larger than ourselves: we and our partner network of testing laboratories, ingredient suppliers, development partners and machinery specialists scale with the brief.

Large programmes ask more of a manufacturer than a single launch:

• One plan. Formats, markets, channels and launch dates in one written plan.
• Capacity ahead of demand. Production planned against your rolling forecast.
• Secure supply. Approved second sources for critical materials, and safety stock where there is only one.
• Quality in writing. A quality agreement and a monthly KPI report.
• Documents for every market. Specifications, test results, stability data and labels for the UK, the EU and the US, plus what Amazon US and TikTok Shop US ask for.

Running a programme: forecast, supply, quality agreement, launch

Every programme runs through the same eight stages, with your sign-off at every gate.

1. Mutual NDA and programme brief. Formats, markets, channels, launch windows and the business responsible for each label.
2. Programme plan. A written plan naming every stage, owner and decision, run by a named programme lead.
3. Screening and formulation. Every ingredient checked for each market, and one formula built for the strictest market on the plan, or the fewest variants that work.
4. Capacity and supply plans. Production reserved against your rolling forecast, critical materials secured and second sources approved.
5. Quality agreement. Signed before first production, with the KPIs we report.
6. Pilot and scale-up. A pilot batch on production equipment, then stability in the final pack.
7. Launch sequence. Labels, notifications and documents prepared for each market in the order you launch.
8. Release and review. Every batch tested by accredited partner laboratories as part of every order and released by quality control, with KPIs reported every month.

Capacity planning

Capacity is planned, not assumed. You share a rolling forecast and update it on an agreed cycle; we reserve production against it, order first the materials that take longest to source, and agree a firm-order window inside it. When a programme outgrows today's plan, we add shifts, trained operators and equipment, sourced through our machinery partners, before the forecast needs them. We publish no capacity figures, because each programme's mix of formats, packs and markets sets its own plan. We group runs into campaigns to cut changeovers, and every changeover ends with a documented line clearance and allergen checks before the next product starts.

Scale-up is a technical step, not a bigger batch. Powders with different particle sizes and densities can separate in transfer, and a low-dose active such as vitamin D must reach every unit in micrograms, so we premix micro-ingredients, blend for a validated time and check uniformity with samples from across the batch. A pilot batch on production equipment proves blend uniformity, flow, fill or deposit weight, moisture and yield before the first commercial run.

Dual sourcing and supply security

One ingredient name can hide different materials, so a second source is qualified, not just found. Vitamin D3 from lanolin or from lichen decides whether a product is vegan, and botanical extracts differ by solvent, ratio and standardised marker. Every supplier is approved before any material is used and reviewed every year. We test the identity of every incoming lot of a dietary ingredient, as FDA's supplement manufacturing rules require for US products, and we rely on a supplier's certificate of analysis for other specifications only after our own results have confirmed it over several lots. Where a material has one source, such as a branded ingredient or a proprietary probiotic strain, we hold safety stock instead. A change of source that changes the grade goes back through stability, and your formula never changes without your written sign-off.

Quality agreements and KPIs

Each programme gets a quality agreement before first production. Your brand stays responsible for the products it sells, wherever they are made, so the agreement puts every responsibility in writing. We model it on FDA's guidance on quality agreements, which was written for contract drug manufacturing rather than supplements and covers change control, materials, laboratory controls, documentation and audits. Our agreements set:

• Who approves specifications and labels, and who releases each batch
• Change control: what we notify, what you approve and how
• Deviations, out-of-specification results, complaints and adverse event reports
• Retained samples, audits by your quality team and mock recalls
• The KPIs we report, against the targets you set

Each month we report on-time, in-full delivery, batches released right first time, open deviations and corrective actions, complaints, supplier performance and forecast accuracy. Each measure is defined in writing: on time and in full means every line complete on the agreed date, and right first time means released without rework or an open deviation. Our quality and accreditations page explains the system behind them.

Launch sequencing across markets

A multi-market launch is a sequence, and each market has its own gate. As of October 2026:

• Great Britain. A label naming a business in the British Islands, with claims from the GB register.
• European Union. An EU operator or importer named on the label, labels in a language consumers in each country easily understand, and a notification with a model of the label in the member states that require one, some of them before the first sale.
• United States. An FDA registered manufacturer, prior notice for each shipment, a new dietary ingredient notification before launch where an ingredient needs one, and an additional 10% tariff on UK goods since 24 July 2026, unless the product's tariff code is exempt.
• Marketplaces. Amazon's US store requires dietary supplements to be verified through a third-party testing, inspection and certification (TIC) organisation, and TikTok Shop's US rules ask for a recent test report from an approved laboratory. Amazon's US GMP verification needs a third-party 21 CFR 111 audit, which we plan around each US programme.

Launch first where your formula and documents are ready, and add markets as their labels and notifications clear. One formula for the strictest market lets one production campaign be packed into each market's labels. On the line, each market's labels are kept apart, checked against approved artwork at the start of every run and reconciled at the end. A UK pouch brand, a client since 2023, grew with us from a small brand into a business selling across Europe, the USA and Mexico: we guided its regulatory and compliance checks for each market and split its shipments across its fulfilment partners. Our page on supplement manufacturing for every market sets out each market's rules, and our supplement regulation watch tracks the changes.

Your large-scale supplement manufacturer, with a named programme lead

• A named programme lead, a written programme plan and a quarterly programme review
• Capacity and supply plans, with approved second sources for critical materials
• A quality agreement and a monthly KPI report
• Screening, labels, claims and documents for the UK, the EU and the US
• Every batch tested by accredited partner laboratories (ISO/IEC 17025) as part of every order, and released by quality control against its specification
• Three retained samples per batch, kept for shelf life plus one year, and a full mock recall, forward and backward with mass balance, in seconds
• Shipments split across your fulfilment partners

We make capsules, tablets, gummies, powders, sachets and stick packs, liquids, shots and sprays, oral pouches, drinks and cosmetics at our facility in Leicestershire. British VitaTech is ISO 9001, HACCP and GMP certified by BSI, and FDA registered. Retailers and brand owners use GFSI-recognised certificates to approve suppliers without auditing every site themselves. BRCGS implementation under way, certification expected in early 2027. R&D is a paid stage that can be included with an order of the right size. We scope it before work begins.

Bringing an existing range? We match it from your own specification, as our guide to moving your supplements to a new manufacturer explains, and our supplement reformulation work upgrades it for new markets and rules. New products start with private label and contract supplement manufacturing.

Why ownership matters twice over at programme scale

Your formula is yours. That holds at any scale: with us, the formula, its specification and the data behind it belong to your brand in every market, and we never sell it or offer it to anyone else. In a large programme it matters twice over, because specifications, stability data, claims reviews and quality records are part of what makes a brand worth owning. Read how formula ownership works.

We sign a mutual NDA before you share a formula, a forecast or a supplier's name, and we protect what you share with restricted access and controlled documents.

Programme dates set with you, and the commitments behind them

We publish no timescales. A programme's plan depends on its formats, markets, materials and forecast, so we set the dates with you in the programme plan. We commit to:

• A written programme plan naming every stage, owner and decision
• Second sources approved for critical materials wherever they exist, and safety stock where they don't
• A quality agreement signed before first production
• Your sign-off at every gate: sample, specification, label and first batch
• No change to your formula without your written sign-off
• Regulatory checks for each market, dated and repeated when the rules change

Share your forecast and your markets. Start your project.

References: US FDA, Contract Manufacturing Arrangements for Drugs: Quality Agreements, guidance for industry (2016); US FDA, current good manufacturing practice for dietary supplements, 21 CFR Part 111 (2007); Regulation (EU) No 1169/2011 on food information to consumers (2011); Directive 2002/46/EC on food supplements (2002); Office of the US Trade Representative, Notice of Actions in Section 301 Investigations (2026); NutraIngredients, Are billion-dollar supplement deals becoming the new benchmark? (2026).